GSA Capital Partners’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-40,794
| Closed | -$399K | – | 1693 |
|
|
2019
Q4 | $399K | Sell |
40,794
-7,746
| -16% | -$75.8K | 0.05% | 818 |
|
|
2019
Q3 | $461K | Sell |
48,540
-3,292
| -6% | -$31.3K | 0.06% | 606 |
|
|
2019
Q2 | $616K | Buy |
+51,832
| New | +$616K | 0.07% | 534 |
|
|
2019
Q1 | – | Sell |
-15,825
| Closed | -$275K | – | 1764 |
|
|
2018
Q4 | $275K | Sell |
15,825
-108,967
| -87% | -$1.89M | 0.03% | 880 |
|
|
2018
Q3 | $1.86M | Sell |
124,792
-14,955
| -11% | -$223K | 0.1% | 276 |
|
|
2018
Q2 | $2.22M | Sell |
139,747
-17,941
| -11% | -$285K | 0.11% | 223 |
|
|
2018
Q1 | $2.24M | Buy |
157,688
+66,838
| +74% | +$949K | 0.12% | 222 |
|
|
2017
Q4 | $1.27M | Sell |
90,850
-20,467
| -18% | -$287K | 0.08% | 450 |
|
|
2017
Q3 | $1.59M | Buy |
111,317
+19,817
| +22% | +$283K | 0.11% | 246 |
|
|
2017
Q2 | $1.44M | Buy |
+91,500
| New | +$1.44M | 0.09% | 295 |
|
|
2016
Q4 | – | Sell |
-66,132
| Closed | -$1.28M | – | 2020 |
|
|
2016
Q3 | $1.28M | Sell |
66,132
-75,758
| -53% | -$1.46M | 0.07% | 469 |
|
|
2016
Q2 | $2.77M | Buy |
141,890
+40,024
| +39% | +$781K | 0.15% | 127 |
|
|
2016
Q1 | $2.1M | Buy |
101,866
+6,494
| +7% | +$134K | 0.13% | 162 |
|
|
2015
Q4 | $1.96M | Buy |
95,372
+79,030
| +484% | +$1.62M | 0.1% | 267 |
|
|
2015
Q3 | $279K | Sell |
16,342
-19,077
| -54% | -$326K | 0.01% | 1406 |
|
|
2015
Q2 | $660K | Sell |
35,419
-26,561
| -43% | -$495K | 0.03% | 1177 |
|
|
2015
Q1 | $1.18M | Buy |
+61,980
| New | +$1.18M | 0.05% | 722 |
|
|
2014
Q4 | – | Sell |
-15,832
| Closed | -$280K | – | 1956 |
|
|
2014
Q3 | $280K | Sell |
15,832
-2,800
| -15% | -$49.5K | 0.01% | 1306 |
|
|
2014
Q2 | $385K | Buy |
+18,632
| New | +$385K | 0.02% | 1290 |
|
|
2014
Q1 | – | Sell |
-22,532
| Closed | -$598K | – | 1859 |
|
|
2013
Q4 | $598K | Buy |
22,532
+6,300
| +39% | +$167K | 0.05% | 709 |
|
|
2013
Q3 | $384K | Buy |
+16,232
| New | +$384K | 0.03% | 971 |
|